Mirri Glow™ Developed by Mirri Diabetes ↗ Investigational Talk to us
Investigational · Not cleared or approved by FDA

MirriGlow™

Look on the light side.

Our patent-pending research is designing the future of diabetes automation, across phone, pump and the clinic’s computer.

Join the light side

Mirri Glow™ is in development and is not for sale. It has not been cleared or approved by FDA. Patent pending.

Mirri Glow home screen with demo data: 110 mg/dL and steady, with the status All good.
Development status

Mirri is developing an investigational automated insulin delivery system for people with type 1 diabetes. The system is being designed to predict impending hypoglycemia from continuous glucose data and to automatically adjust insulin delivery from a connected pump. It is under development, has not been cleared or approved by FDA, and its safety and effectiveness have not been established.

Investigational app · demo data

A first look.

Three moments on the Mirri Glow™ home screen, shown with demo data.

Mirri Glow home screen with demo data: 110 mg/dL and steady, with the status All good.
In rangeSteady at 110 mg/dL, with nothing to do.
Mirri Glow home screen with demo data: 78 mg/dL and heading low, with a carb suggestion.
Heading lowBeing designed to spot a coming low and suggest carbs before it lands.
Mirri Glow home screen with demo data: 300 mg/dL and high, with a correction suggestion.
Running highBeing designed to suggest a correction when glucose runs high.

Mirri Glow™ is in development and is not for sale. It has not been cleared or approved by FDA, and an app that has not been cleared or approved by FDA cannot give medical advice or treatment recommendations. The carb and insulin suggestions on these screens (“Eat 22 g”, “Give 1.2 u”) are demo data shown for illustration only. Do not use them to make treatment decisions.

Illustration

No two days are the same.

Meals, movement, sleep, stress, and everything in between. Drag to explore.

From reading to response
CGM Mirri Glow Pump readings adjustments
Illustration only. The system is investigational, is not available, and has not been cleared or approved by FDA.
Reading the trend
180 70 mg/dL now forecast
It is being designed to look ahead for an impending low from the direction glucose is heading.

Illustrations with synthetic data — not measurements or results from Mirri Glow. Mirri Glow is investigational: it has not been cleared or approved by FDA, and its safety and effectiveness have not been established.

Contact

Join the light side.

We're quiet about the details for now. But if you research diabetes or build the technology around it, we'd love your brain on this. A human replies, usually within a day.

Say hello hello@mirridiabetes.com
Replies from a human, not a bot.
Mirri Glow™

Mirri Glow™ is in development and is not for sale. It has not been cleared or approved by FDA, and its safety and effectiveness have not been established. Patent pending.

© 2026 Mirri Diabetes.